Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/11/1996 | CN1130631A Cyclodlkano-indole and-azaindole derivatives |
09/11/1996 | CN1130630A Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses |
09/11/1996 | CN1130626A Adhesion receptor antagonists |
09/11/1996 | CN1130532A Modulation of cellular activity |
09/11/1996 | CN1130513A Medicine for treating self-biting disease for fox and preparing process thereof |
09/11/1996 | CN1130510A Process for preparing contraceptive |
09/11/1996 | CN1130509A Microcapsulated zinc gluconate and producing process thereof |
09/11/1996 | CN1130508A Two medicines for treating Parkinson's disease and presenile dementia and preparing process thereof |
09/11/1996 | CN1130507A Use of novel 1 alpha-hydroxy vitamin D4 |
09/11/1996 | CN1130506A Pharmaceutical formulations of cefaclor |
09/11/1996 | CN1130505A Use of 5-acyl-1,4-dihydropyridines |
09/11/1996 | CN1130485A Omega-3omega-6 fatty acid series health food |
09/11/1996 | CN1032756C Method for preparing ursodeoxycholic acid using fowl gall as raw material |
09/11/1996 | CN1032755C Human placental nucleic acid extracting method |
09/11/1996 | CN1032754C Process for preparing immunostimulating 6-aryl-5,6-dihydroimidazo |2,1-b¨ thiazole derivatives |
09/11/1996 | CN1032752C 4-carboxyl-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-formamide-1,1-dioxygen derivant and its preparation process |
09/11/1996 | CN1032751C Thiazolidine compound, preparing process thereof and its application in medicine |
09/11/1996 | CN1032750C Process for prepn. of ureido derivatives of poly 4-amino-2-carboxy-1-methyl compounds |
09/11/1996 | CA2171404A1 3-benzyl-benzothiophenes |
09/11/1996 | CA2171403A1 .alpha. substituted-1-benzyl-naphthyls |
09/11/1996 | CA2171399A1 Substituted-3-benzyl-benzofurans |
09/11/1996 | CA2170968A1 Preparation of d4t from 5-methyluridine |
09/10/1996 | US5554789 Arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent |
09/10/1996 | US5554772 N-(3-hydroxy-4-piperidinyl) dihydrobenzofuran, (dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
09/10/1996 | US5554756 Amino acid derivatives |
09/10/1996 | US5554755 Acylation |
09/10/1996 | US5554655 Method of treating HIV infection |
09/10/1996 | US5554654 Method for enhancing the therapeutic effect of an anti-acne agent |
09/10/1996 | US5554653 Inhibitors of HIV protease useful for the treatment of AIDS |
09/10/1996 | US5554652 Topically applying mixture to reduce or prevent skin disorders |
09/10/1996 | US5554651 Method of treating wrinkles using citramalic acid |
09/10/1996 | US5554650 Mixture of diclofenac or salt with water and surfactants; side effect reduction |
09/10/1996 | US5554646 Method for reducing body fat in animals |
09/10/1996 | US5554645 Antineoplastic cocoa extracts and methods for making and using the same |
09/10/1996 | US5554643 Pro-drugs for CCK antagonists |
09/10/1996 | US5554642 Arylalkyl(thio) amides |
09/10/1996 | US5554641 Nonpeptides as tachykinin antagonists |
09/10/1996 | US5554639 Medicaments |
09/10/1996 | US5554638 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
09/10/1996 | US5554637 Use of leflunomide for inhibiting interleukin 1 alpha |
09/10/1996 | US5554636 N-acylated 4-hydroxphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them |
09/10/1996 | US5554634 N-(hydroxyethyl)butanediamide derivatives |
09/10/1996 | US5554632 Central nervous system |
09/10/1996 | US5554631 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinyl benzimidazole derivatives |
09/10/1996 | US5554629 Headaches |
09/10/1996 | US5554628 Method for minimizing the uterothrophic effect of tamoxifen and tamoxifen analogs |
09/10/1996 | US5554626 Substituted heterocyclic compounds as dopamine-reuptake inhibitors |
09/10/1996 | US5554625 Substituted biphenylmethylimidazopyridines |
09/10/1996 | US5554624 Imidazopyridine derivatives as angiotensin II antagonists |
09/10/1996 | US5554623 Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates |
09/10/1996 | US5554622 Asymmetrically substituted bisnaphthalimides |
09/10/1996 | US5554621 Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives |
09/10/1996 | US5554620 Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof |
09/10/1996 | US5554618 Intravenously administrable aqueous solution |
09/10/1996 | US5554614 Treatment of psychological disorders, psychoses; analgesics |
09/10/1996 | US5554613 Quinuclidine derivatives, qualene synthase inhibitors, treatment of hypercholesterolemia, atherosclerosis and fungus infections |
09/10/1996 | US5554612 Immunosuppressants, viricides, antitumor and antiinflammatory agents |
09/10/1996 | US5554611 Use of coumarin derivatives |
09/10/1996 | US5554610 Inhalational treatment of pulmonary hypertension and related conditions |
09/10/1996 | US5554607 Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis |
09/10/1996 | US5554604 Method of controlling male fertility |
09/10/1996 | US5554603 Orally active derivatives of 1,3,5(10)-estratriene |
09/10/1996 | US5554601 Administering an estrogen compound in the absence of testosterone; treatment of alzheimer*s |
09/10/1996 | US5554600 Methods for inhibiting endometriosis |
09/10/1996 | US5554599 22-thio vitamin D derivatives |
09/10/1996 | US5554598 Method of treating crural or decubitus ulcer with zinc hyaluroric acid complex |
09/10/1996 | US5554597 Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging |
09/10/1996 | US5554596 Polymer with lignin units and lignoid units |
09/10/1996 | US5554595 Selective regulation of B lymphocyte precursors by hormones |
09/10/1996 | US5554594 Imidazolidine derivatives |
09/10/1996 | US5554538 DNA sequences derived from papillomavirus HPV-33 genome |
09/10/1996 | US5554384 High dose formulations of mycophenolate mofetil and mycophenolic acid |
09/10/1996 | US5554383 Administering selective serotonin reuptake inhibitor |
09/10/1996 | US5554381 Low flux matrix system for delivering potent drugs transdermally |
09/10/1996 | US5554367 Compositions for treatment of glaucoma |
09/10/1996 | US5554365 Use of cyanoacrylate adhesive compositions to inhibit acute radiation-induced skin damage |
09/10/1996 | US5554360 Low-irritant shampoo composition |
09/10/1996 | US5554359 Stimulating melanogenesis in human skin cells by topically applying composition comprising lysosomotropic agent capable of increasing levels of melanin in human melanocyte and topical carrier |
09/10/1996 | US5554110 Medical ablation apparatus |
09/10/1996 | CA2171081A1 Use of 6,7-substitute-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions |
09/10/1996 | CA2170818A1 Method of treating cardiac inflammatory disease |
09/10/1996 | CA2067759C 3-phenyglutarimide derivatives as muscarinic receptor antagonists |
09/10/1996 | CA2038629C Oleandomycin oximes, preparation and use thereof |
09/10/1996 | CA2036507C 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
09/10/1996 | CA2011468C Sodium n-acetylneuraminate trihydrate and method for the preparation thereof |
09/10/1996 | CA2009890C Valproic acid |
09/07/1996 | CA2171057A1 Corneal opacification inhibitory composition |
09/07/1996 | CA2170824A1 N-(3-benzofuranyl)urea-derivatives |
09/06/1996 | WO1996027008A2 Agent for treating tumours and other hyperplasia |
09/06/1996 | WO1996027006A2 Human vegf-specific antisense oligonucleotides |
09/06/1996 | WO1996026950A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
09/06/1996 | WO1996026944A1 Clavulanic acid salts |
09/06/1996 | WO1996026943A1 Derivatives of 3-pyrrolidylidene-2-one-cephalosporines |
09/06/1996 | WO1996026937A1 Prokinetic oxadiazoles |
09/06/1996 | WO1996026935A1 2-benzyl-3-arylbenzothiophenes |
09/06/1996 | WO1996026933A1 Novel selective inhibitors of viral or bacterial neuraminidases |
09/06/1996 | WO1996026932A1 2-arylbenzazole compounds |
09/06/1996 | WO1996026931A1 Optically active thiazolidinone derivatives |
09/06/1996 | WO1996026929A1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds |
09/06/1996 | WO1996026928A1 Novel derivatives of ethyl-1 dihydro-1,2 oxo-2 methylamino-3 quinoxaline, utilization as drugs, and pharmaceutical compositions containing them |